Literature DB >> 18465661

Herpesviruses and autoimmunity.

David N Posnett1.   

Abstract

Herpesvirus infection, in particular EBV infection, has been implicated in several major autoimmune diseases, including systemic lupus erythematosus (SLE), multiple sclerosis (MS) and rheumatoid arthritis (RA). Herpesvirus infection has potential roles in both initiating the autoimmune process and exacerbating disease progression. In particular, EBV has a proposed role in initiating the anti-nucleoprotein antibodies that are characteristic of SLE through molecular mimicry. There is also evidence to suggest that there is productive infection with EBV in the brain lesions of MS patients and in the synovium of RA patients. Research has been conducted in a mouse gamma-herpesvirus model, as it serves as a useful model for productive infection within autoimmune target tissues. The novel mechanisms by which EBV could contribute bystander effects by amplification of innate immune responses, along with preclinical and epidemiological studies into the role of herpesviruses in SLE, MS and RA, and clinical studies into the potential benefit of antiviral therapy, are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18465661

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  26 in total

1.  Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.

Authors:  Costanza Casiraghi; Ana Citlali Márquez; Iryna Shanina; Marc Steven Horwitz
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

2.  High mean platelet volume-to-platelet count ratio as a diagnostic maker for increased risk of liver function damage in pediatric patients with infectious mononucleosis in China.

Authors:  Xiucui Han; Pengfei Xu; Xiuzhi Duan; Yongxia Liu; Junfeng Zhang; Hui Xu
Journal:  Exp Ther Med       Date:  2019-10-15       Impact factor: 2.447

Review 3.  Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.

Authors:  Liisa K Selin; Myriam F Wlodarczyk; Anke R Kraft; Siwei Nie; Laurie L Kenney; Roberto Puzone; Franco Celada
Journal:  Autoimmunity       Date:  2011-01-20       Impact factor: 2.815

4.  HPV and systemic lupus erythematosus: a mosaic of potential crossreactions.

Authors:  Yahel Segal; Shani Dahan; Michele Calabrò; Darja Kanduc; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

5.  Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection.

Authors:  Ikuo Tsunoda
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

Review 6.  The pathogenesis of Epstein-Barr virus persistent infection.

Authors:  David A Thorley-Lawson; Jared B Hawkins; Sean I Tracy; Michael Shapiro
Journal:  Curr Opin Virol       Date:  2013-05-15       Impact factor: 7.090

7.  CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.

Authors:  R M Leskowitz; X Y Zhou; F Villinger; M H Fogg; A Kaur; P M Lieberman; F Wang; H C Ertl
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

8.  A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis.

Authors:  John M Davis; Keith L Knutson; John A Skinner; Michael A Strausbauch; Cynthia S Crowson; Terry M Therneau; Peter J Wettstein; Eric L Matteson; Sherine E Gabriel
Journal:  Arthritis Res Ther       Date:  2012-01-31       Impact factor: 5.156

9.  Exacerbated metastatic disease in a mouse mammary tumor model following latent gammaherpesvirus infection.

Authors:  Vinita S Chauhan; Daniel A Nelson; Lopamudra Das Roy; Pinku Mukherjee; Kenneth L Bost
Journal:  Infect Agent Cancer       Date:  2012-05-29       Impact factor: 2.965

10.  Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.

Authors:  Daniela F Angelini; Barbara Serafini; Eleonora Piras; Martina Severa; Eliana M Coccia; Barbara Rosicarelli; Serena Ruggieri; Claudio Gasperini; Fabio Buttari; Diego Centonze; Rosella Mechelli; Marco Salvetti; Giovanna Borsellino; Francesca Aloisi; Luca Battistini
Journal:  PLoS Pathog       Date:  2013-04-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.